Ketamine shown to act as antidepressant by boosting serotonin
HONG KONG – The results of a positron emission tomography (PET) molecular imaging study in monkeys suggest that the anesthetic, ketamine, may help in the diagnosis of major depressive disorder in humans and development of new antidepressants, report Japanese researchers from the Riken Center for Life Science Technologies.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter